Add like
Add dislike
Add to saved papers

Improved evaluation of technetium-99m-red blood cell SPECT in hemangioma of the liver.

This paper reports the results of a prospective study carried out to evaluate a new reading method of tomographic 99mTc red blood cell (RBC) imaging in liver hemangiomas. For this purpose, assessment of planar imaging and conventional, static 99mTc-RBC SPECT presentation (x-ray type film) (Method 1) was compared to a dynamic three-view display of SPECT slices (Method 2) in 21 patients with 56 hemangiomas and 18 patients with malignant liver lesions. Of the 56 hemangiomas, 47 were diagnosed by US, 6 by CT and 56 by MRI. Twenty-nine (52%) hemangiomas were detected by planar scintigraphy and 38 (68%) by SPECT Method 1, whereas 53 (95%) were visualized by SPECT Method 2. Comparing Methods 1 and 2 in hemangiomas < or = 1.0 cm, 1.1-2.0 cm and 2.1-3.0 cm in diameter, Method 2 improved sensitivity from 18% to 82%, 50% to 93% and 82% to 100%, respectively. The smallest hemangioma detected with Method 2 was 0.5 cm in diameter; with Method 1, 0.9 cm; and with planar imaging, 1.0 cm. As assessed by evaluation of the metastases and carcinomas, the specificity for hemangioma was 100%, independent of the method applied, resulting in a positive predictive value of 100%. This study suggests that evaluation of dynamically displayed 99mTc-RBC SPECT studies is superior to conventional reading of static display and comparable to MRI in liver hemangioma > or = 1 cm. Therefore, this approach is suggested as an alternative to MRI for confirming the diagnosis of liver hemangioma > or = 1 cm if planar imaging is negative. This option is available with most modern computer software systems and saves additional disbursement.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app